Search Results
Capecitabine remains the adjuvant standard of care for TNBC with residual disease | Ingrid Mayer
For Residual TNBC Post-Chemo, Capecitabine Should Be Offered
Dr. Goetz On Adjuvant Capecitabine Following Neoadjuvant Chemotherapy and Surgery
Tackling residual disease in breast cancer
The Immune Landscape of Residual TNBC After Neoadjuvant Chemotherapy
FOCUS4-N: Maintenance capecitabine monotherapy in mCRC
Educational Sessions: "IO vs Capecitabine for TNBC"
What to do in patients with early-stage TNBC who have not achieved a pCR?
Next Step - Adjuvant Therapy - Chemo Pill - Xeloda | Our Journey
Xeloda (capecitabine)
Results from adding adjuvant capecitabine to treatment for breast cancer patients
Dr. Ingrid Mayer, USA
